🇺🇸 FDA

Company profile · Sponsor

Daihong

Daihong Liu

CEA7A27 · NMPA pharma CN
Pipeline
1
Drugs
0
Patents
0

Quick answer

Daihong (CEA7A27) is a pharma company. headquartered in CN. listed on NMPA. NovaPharmaNews links 1 pipeline program, 0 drugs, and 0 patents to this profile..

Company facts

Ticker CEA7A27
Exchange NMPA
Company type pharma
Headquarters CN

Pipeline (1)

Search pipeline →

  1. CAR-T Cell Therapy + Chidamide and PD-1 Inhibitor Maintenance

    Daihong

    Relapsed or Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL)

    phase 2 small molecule active

    1 trial

Frequently asked questions

What is Daihong?

Daihong (CEA7A27) is a pharma company. headquartered in CN. listed on NMPA. NovaPharmaNews links 1 pipeline program, 0 drugs, and 0 patents to this profile..

What pipeline programs does Daihong sponsor?

We track 1 ClinicalTrials.gov-linked program for Daihong, including CAR-T Cell Therapy + Chidamide and PD-1 Inhibitor Maintenance. Open each program for phase, modality, NCT IDs, and indication details.

Where does Daihong company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.